Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.
- 1 April 2000
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (4) , 339-349
- https://doi.org/10.2165/00019053-200017040-00004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Problems with Interval Estimates of the Incremental Cost—Effectiveness RatioMedical Decision Making, 1999
- Carrier Screening for Cystic FibrosisMedical Decision Making, 1998
- Confidence intervals for cost-effectiveness ratios: An application of Fieller's theoremHealth Economics, 1996
- Statistical Analysis in Pharmacoeconomic StudiesPharmacoEconomics, 1996
- Confidence intervals for cost/effectiveness ratiosHealth Economics, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- Statistical Versus Quantitative Significance in the Socioeconomic Evaluation of MedicinesPharmacoEconomics, 1994
- Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trialCritical Care Medicine, 1994
- A Bayesian approach to parallel line bioassayBiometrika, 1980
- Note on a Conditional Property of Student's $t^1$The Annals of Mathematical Statistics, 1963